BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16464164)

  • 1. Peptidomics biomarker discovery in mouse models of obesity and type 2 diabetes.
    Budde P; Schulte I; Appel A; Neitz S; Kellmann M; Tammen H; Hess R; Rose H
    Comb Chem High Throughput Screen; 2005 Dec; 8(8):775-81. PubMed ID: 16464164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prerequisites for peptidomic analysis of blood samples: II. Analysis of human plasma after oral glucose challenge -- a proof of concept.
    Tammen H; Hess R; Schulte I; Kellmann M; Appel A; Budde P; Zucht HD; Schulz-Knappe P
    Comb Chem High Throughput Screen; 2005 Dec; 8(8):735-41. PubMed ID: 16464160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative peptidomics of the endocrine pancreas: islet hormones from the clawed frog Xenopus laevis and the red-bellied newt Cynops pyrrhogaster.
    Conlon JM; Kim JB; Johansson A; Kikuyama S
    J Endocrinol; 2002 Dec; 175(3):769-77. PubMed ID: 12475387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidomic profiling of secreted products from pancreatic islet culture results in a higher yield of full-length peptide hormones than found using cell lysis procedures.
    Taylor SW; Nikoulina SE; Andon NL; Lowe C
    J Proteome Res; 2013 Aug; 12(8):3610-9. PubMed ID: 23746063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concept of functional peptidomics for the discovery of bioactive peptides in cell culture models.
    Jost MM; Budde P; Tammen H; Hess R; Kellmann M; Schulte I; Rose H
    Comb Chem High Throughput Screen; 2005 Dec; 8(8):767-73. PubMed ID: 16464163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the human pancreatic islet proteome by two-dimensional LC/MS/MS.
    Metz TO; Jacobs JM; Gritsenko MA; Fontès G; Qian WJ; Camp DG; Poitout V; Smith RD
    J Proteome Res; 2006 Dec; 5(12):3345-54. PubMed ID: 17137336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
    Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
    Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidomics: A Review of Clinical Applications and Methodologies.
    Foreman RE; George AL; Reimann F; Gribble FM; Kay RG
    J Proteome Res; 2021 Aug; 20(8):3782-3797. PubMed ID: 34270237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined lipidomic and proteomic analysis of isolated human islets exposed to palmitate reveals time-dependent changes in insulin secretion and lipid metabolism.
    Roomp K; Kristinsson H; Schvartz D; Ubhayasekera K; Sargsyan E; Manukyan L; Chowdhury A; Manell H; Satagopam V; Groebe K; Schneider R; Bergquist J; Sanchez JC; Bergsten P
    PLoS One; 2017; 12(4):e0176391. PubMed ID: 28448538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
    Greening DW; Kapp EA; Simpson RJ
    Enzymes; 2017; 42():27-64. PubMed ID: 29054270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peptidomics concept.
    Schulz-Knappe P; Schrader M; Zucht HD
    Comb Chem High Throughput Screen; 2005 Dec; 8(8):697-704. PubMed ID: 16464157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice.
    O'Harte FP; Mooney MH; Kelly CM; McKillop AM; Flatt PR
    Regul Pept; 2001 Jan; 96(3):95-104. PubMed ID: 11111014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Peptide tumor markers in a tumor graft model in immunodeficient mice.
    Tammen H; Schorn K; Selle H; Hess R; Neitz S; Reiter R; Schulz-Knappe P
    Comb Chem High Throughput Screen; 2005 Dec; 8(8):783-8. PubMed ID: 16464165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.
    El Ouaamari A; Zhou JY; Liew CW; Shirakawa J; Dirice E; Gedeon N; Kahraman S; De Jesus DF; Bhatt S; Kim JS; Clauss TR; Camp DG; Smith RD; Qian WJ; Kulkarni RN
    J Proteome Res; 2015 Aug; 14(8):3111-3122. PubMed ID: 26151086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradome.
    Scholz B; Sköld K; Kultima K; Fernandez C; Waldemarson S; Savitski MM; Söderquist M; Borén M; Stella R; Andrén P; Zubarev R; James P
    Mol Cell Proteomics; 2011 Mar; 10(3):M900229MCP200. PubMed ID: 20110281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides in body fluids and tissues as markers of disease.
    Schulte I; Tammen H; Selle H; Schulz-Knappe P
    Expert Rev Mol Diagn; 2005 Mar; 5(2):145-57. PubMed ID: 15833045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).
    Wu SL; Kim J; Hancock WS; Karger B
    J Proteome Res; 2005; 4(4):1155-70. PubMed ID: 16083266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.